|1.||National governments, working in collaboration with international and non-governmental organizations, should develop and implement comprehensive programs for the screening, prevention and treatment of organ failure, which include:
|a.||The advancement of clinical and basic science research;|
|b.||Effective programs, based on international guidelines, to treat and maintain patients with end-stage diseases, such as dialysis programs for renal patients, to minimize morbidity and mortality, alongside transplant programs for such diseases;|
|c.||Organ transplantation as the preferred treatment for organ failure for medically suitable recipients.|
|2.||Legislation should be developed and implemented by each country or jurisdiction to govern the recovery of organs from deceased and living donors and the practice of transplantation, consistent with international standards.|
|a.||Policies and procedures should be developed and implemented to maximize the number of organs available for transplantation, consistent with these principles;|
|b.||The practice of donation and transplantation requires oversight and accountability by health authorities in each country to ensure transparency and safety;|
|c.||Oversight requires a national or regional registry to record deceased and living donor transplants;|
|d.||Key components of effective programs include public education and awareness, health professional education and training, and defined responsibilities and accountabilities for all stakeholders in the national organ donation and transplant system.|
|3.||Organs for transplantation should be equitably allocated within countries or jurisdictions to suitable recipients without regard to gender, ethnicity, religion, or social or financial status.|
a. Financial considerations or material gain of any party must not influence the application of relevant allocation rules.
|4.||The primary objective of transplant policies and programs should be optimal short- and long-term medical care to promote the health of both donors and recipients.|
|a.||Financial considerations or material gain of any party must not override primary consideration for the health and well-being of donors and recipients.|
|5.||Jurisdictions, countries and regions should strive to achieve self-sufficiency in organ donation by providing a sufficient number of organs for residents in need from within the country or through regional cooperation.|
|a.||Collaboration between countries is not inconsistent with national self- sufficiency as long as the collaboration protects the vulnerable, promotes equality between donor and recipient populations, and does not violate these principles;|
|b.||Treatment of patients from outside the country or jurisdiction is only acceptable if it does not undermine a country’s ability to provide transplant services for its own population.
|6.||Organ trafficking and transplant tourism violate the principles of equity, justice and respect for human dignity and should be prohibited. Because transplant commercialism targets impoverished and otherwise vulnerable donors, it leads inexorably to inequity and injustice and should be prohibited. In Resolution 44.25, the World Health Assembly called on countries to prevent the purchase and sale of human organs for transplantation.|
|a.||Prohibitions on these practices should include a ban on all types of advertising (including electronic and print media), soliciting, or brokering for the purpose of transplant commercialism, organ trafficking, or transplant tourism.
|b.||Such prohibitions should also include penalties for acts—such as medically screening donors or organs, or transplanting organs—that aid, encourage, or use the products of, organ trafficking or transplant tourism.|
|c.||Practices that induce vulnerable individuals or groups (such as illiterate and impoverished persons, undocumented immigrants, prisoners, and political or economic refugees) to become living donors are incompatible with the aim of combating organ trafficking, transplant tourism and transplant commercialism.|